— Mallinckrodt plc (NYSE: MNK) reported third-quarter 2019 earnings of $2.07 per share, vs. $1.97 per share expected. — Revenue fell 7% to $743.7 million, vs. $770.8 million expected. Acthar Gel net sales were $229.8 million, down 20.8% YoY. — Raised fiscal year 2019 adjusted EPS guidance range to $8.50 – $8.70, from the prior […]
— Mallinckrodt plc (NYSE: MNK) reported third-quarter 2019 earnings of $2.07 per share, vs. $1.97 per share expected. — Revenue fell 7% to $743.7 million, vs. $770.8 million expected. Acthar Gel net sales were $229.8 million, down 20.8% YoY. — Raised fiscal year 2019 adjusted EPS guidance range to $8.50 – $8.70, from the prior […]
— Mallinckrodt plc (NYSE: MNK) reported third-quarter 2019 earnings of $2.07 per share, vs. $1.97 per share expected.
— Revenue fell 7% to $743.7 million, vs. $770.8 million expected. Acthar Gel net sales were $229.8 million, down 20.8% YoY.
— Raised fiscal year 2019 adjusted EPS guidance range to $8.50 – $8.70, from the prior estimate of $8.40 – $8.70
— MNK shares rose 2.3% immediately following the announcement.
